Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

FDMT. – 4D Molecular Therapeutics Inc

FDMT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

24.21

Margin Of Safety %

Put/Call OI Ratio

0.11

EPS Next Q Diff

-0.01

EPS Last/This Y

-1.53

EPS This/Next Y

0.13

Price

10.76

Target Price

28.67

Analyst Recom

1.2

Performance Q

8.26

Upside

-421.7%

Beta

2.68

Ticker: FDMT



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13FDMT11.30.08999.995627
2026-07-14FDMT11.690.1411.255934
2026-07-15FDMT11.680.140.005932
2026-07-16FDMT10.820.140.015923
2026-07-17FDMT10.980.142.785956
2026-07-20FDMT11.070.080.064691
2026-07-21FDMT11.370.080.735002
2026-07-22FDMT10.960.08999.995068
2026-07-23FDMT10.370.080.365077
2026-07-24FDMT10.080.0834.005166
2026-07-27FDMT10.40.0834.005166
2026-07-28FDMT9.830.083.815166
2026-07-29FDMT9.60.100.805247
2026-07-30FDMT10.050.101.115247
2026-07-31FDMT10.180.1010.005255
2026-08-03FDMT10.080.102.635268
2026-08-04FDMT10.260.10999.995273
2026-08-05FDMT10.270.10999.995280
2026-08-07FDMT10.760.114.405294
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13FDMT11.31-3.4- -3.93
2026-07-14FDMT11.71-3.4- -3.93
2026-07-15FDMT11.68-3.4- -3.93
2026-07-16FDMT10.81-3.4- -3.93
2026-07-17FDMT10.98-3.4- -3.93
2026-07-20FDMT11.07-3.4- -3.93
2026-07-21FDMT11.38-3.4- -3.93
2026-07-22FDMT10.97-3.4- -3.93
2026-07-23FDMT10.38-3.4- -3.93
2026-07-24FDMT10.07-3.4- -3.93
2026-07-27FDMT10.37-3.4- -3.93
2026-07-28FDMT9.83-3.4- -3.93
2026-07-29FDMT9.59-3.4- -3.93
2026-07-30FDMT10.06-3.4- -3.93
2026-07-31FDMT10.18-3.4- -3.93
2026-08-03FDMT10.07-3.4- -3.93
2026-08-04FDMT10.07-3.4- -3.93
2026-08-05FDMT10.29-3.4- -3.93
2026-08-06FDMT10.55-3.4- -3.93
2026-08-07FDMT10.76-3.7- -3.95
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13FDMT-2.30-0.7028.38
2026-07-14FDMT-2.30-0.7028.38
2026-07-15FDMT-3.32-0.7028.38
2026-07-16FDMT-3.32-0.7028.38
2026-07-17FDMT-3.32-0.7028.38
2026-07-20FDMT-3.32-0.7528.38
2026-07-21FDMT-3.32-0.7528.38
2026-07-22FDMT-3.35-0.7528.34
2026-07-23FDMT-3.35-0.7528.34
2026-07-24FDMT-3.35-0.7528.34
2026-07-27FDMT-3.35-1.0324.21
2026-07-28FDMT-3.35-1.0324.21
2026-07-29FDMT-3.35-1.0324.21
2026-07-30FDMT-3.35-1.0324.21
2026-07-31FDMT-3.35-1.0324.21
2026-08-03FDMT-3.35-1.1924.21
2026-08-04FDMT-3.35-1.1924.21
2026-08-05FDMT-4.04-1.1924.21
2026-08-06FDMT-4.04-1.1924.21
2026-08-07FDMT-4.04-1.1924.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-1.01

Avg. EPS Est. Current Quarter

-1.02

Avg. EPS Est. Next Quarter

-1.02

Insider Transactions

-4.04

Institutional Transactions

-1.19

Beta

2.68

Average Sales Estimate Current Quarter

2

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

22

Growth Score

53

Sentiment Score

61

Actual DrawDown %

70.3

Max Drawdown 5-Year %

-93

Target Price

28.67

P/E

Forward P/E

PEG

P/S

6.37

P/B

1.24

P/Free Cash Flow

EPS

-2.66

Average EPS Est. Cur. Y​

-3.95

EPS Next Y. (Est.)

-3.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-182.34

Relative Volume

0.41

Return on Equity vs Sector %

-62.9

Return on Equity vs Industry %

-46.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ FDMT Healthcare
$10.75
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
21/25
Volume
11/15
Valuation
10/20
TP/AR
2/10
Options
6/10
RSI
51.1
Range 1M
33.8%
Sup Dist
4.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
23 /100
WEAK
Momentum
5/25
Growth
7/30
Estimates
2/20
Inst/Vol
2/15
Options
7/10
EPS Yr
-67.6%
EPS NY
-1.4%
52W%
62.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +166.7% upside
Quality
6/30
Valuation
15/30
Growth
2/25
Stability
8/10
LT Trend
3/5
Upside
+166.7%
Quality
22
Click a card to see score breakdown Full Analysis →
FDMT — P/E HistoricalBiotechnology
4D Molecular Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 196
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; and 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd. The company was founded in 2013 and is headquartered in EmeryVille, California.
FDMT

Latest News

—
Caricamento notizie per FDMT…
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading